Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Resectable NSCLC × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2296 Neoplasms 1669 Prostatic Neoplasms 1190 Lung Neoplasms 878 Carcinoma, Non-Small-Cell Lung 841 Colorectal Neoplasms 836 Leukemia, Myeloid, Acute 592 Pancreatic Neoplasms 571 Multiple Myeloma 530 Carcinoma, Hepatocellular 507 Brain Neoplasms 492 Neoplasm Metastasis 467 Head and Neck Neoplasms 444 Melanoma 409 Ovarian Neoplasms 407 Precursor Cell Lymphoblastic Leukemia-Lymphoma 403 Glioblastoma 377 Stomach Neoplasms 374 Squamous Cell Carcinoma of Head and Neck 362 Uterine Cervical Neoplasms 346 Recurrence 338 Colonic Neoplasms 332 Hematologic Neoplasms 329 Sarcoma 319 Rectal Neoplasms 317 Lymphoma 316 Triple Negative Breast Neoplasms 289 Carcinoma, Renal Cell 285 Urinary Bladder Neoplasms 272 Glioma 272

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07492342 2026-03-25

K-NADIR

The First Affiliated Hospital of Guangzhou Medical University

Phase 2 Recruiting

Resectable NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡